The information contained in this release was correct as at
https://www.londonstockexchange.com/exchange/news/market-news/market-news-home.html .
All information is at
Performance at month end with net income reinvested
|
One Month |
Three Months |
One Year |
Three Years |
Five Years |
Since 1 April 2012 |
Sterling |
|
|
|
|
|
|
Share price |
1.9% |
4.3% |
7.2% |
22.0% |
55.4% |
160.4% |
Net asset value |
-0.7% |
1.8% |
4.8% |
29.8% |
61.2% |
156.8% |
FTSE All-Share Total Return |
0.9% |
5.4% |
12.6% |
38.6% |
77.7% |
169.4% |
|
|
|
|
|
|
|
Source: BlackRock |
|
|
|
|
|
|
BlackRock took over the investment management of the Company with effect from
At month end
Sterling:
Net asset value - capital only: |
228.45p |
Net asset value - cum income*: |
232.55p |
Share price: |
211.00p |
Total assets (including income): |
£50.6m |
Discount to cum-income NAV: |
9.3% |
Gearing: |
6.0% |
Net yield**: |
3.6% |
Ordinary shares in issue***: |
19,164,110 |
Gearing range (as a % of net assets): |
0-20% |
Ongoing charges****: |
1.15% |
* Includes net revenue of 4.10 pence per share |
|
** The Company's yield based on dividends announced in the last 12 months as at the date of the release of this announcement is 3.6% and includes the 2024 final dividend of 4.90p per share declared on |
|
*** excludes 10,081,532 shares held in treasury. |
|
**** The Company's ongoing charges are calculated as a percentage of average daily net assets and using management fee and all other operating expenses excluding finance costs, direct transaction costs, custody transaction charges, VAT recovered, taxation and certain non-recurring items for the year ended
|
Sector Analysis |
Total assets (%) |
Banks |
10.6 |
Pharmaceuticals & Biotechnology |
8.4 |
Support Services |
6.1 |
Nonequity Investment Instruments |
6.0 |
|
5.8 |
Financial Services |
5.8 |
Software & Computer Services |
5.1 |
|
4.9 |
Mining |
4.6 |
Tobacco |
4.4 |
General Retailers |
4.1 |
|
3.9 |
Aerospace & Defence |
3.8 |
Personal Goods |
3.7 |
Real Estate Investment Trusts |
3.4 |
Electronic & |
2.8 |
Travel & Leisure |
2.5 |
|
2.3 |
Life Insurance |
2.3 |
Food Producers |
1.4 |
General Industrials |
1.0 |
Beverages |
0.5 |
Net Current Assets |
6.6 |
|
----- |
Total |
100.0 |
|
===== |
Country Analysis |
Percentage
|
|
91.1 |
|
2.3 |
Net Current Assets |
6.6 |
|
----- |
|
100.0 |
|
|
Top 10 Holdings |
Fund %
|
AstraZeneca |
8.0 |
RELX |
5.4 |
British American Tobacco |
4.7 |
Shell |
4.5 |
Unilever |
4.0 |
Standard Chartered |
3.7 |
Lloyds Banking Group |
3.6 |
|
3.4 |
Reckitt |
3.4 |
London Stock Exchange Group |
3.2 |
|
|
|
|
|
|
Commenting on the markets, representing the Investment Manager noted:
Market Summary:
August delivered another strong month for global equities. The
S&P 500
notched multiple record highs, extending its monthly winning streak with a return of over
2%
for the fourth consecutive month. The
MSCI ACWI
rose by
2.5%, reflecting broad-based optimism across developed markets. Investor sentiment was buoyed by the
extension of US-China trade talks
and inflation data that increased expectations for
a
The month began with a
disappointing US July non-farm payrolls report, showing job growth of just
+73,000, alongside significant downward revisions to prior months. The
unemployment rate
rose to
4.2%, although remains low by historical standards. Bond markets responded with the
2-year
In European markets, growth remained sluggish amid delays in the
US-EU trade deal, which weighed on equity performance.
Banks outperformed given strong results during the month. The
In the
Stock comments
Detractors for the month were due to stock specific and macro factors, including detractors around broader market concerns for the future of AI, and ongoing pressure on
RELX was the second largest detractor from performance over the month. RELX was hit following a negative read across from Gartner, a research and advisory firm, which was down as much as c.40% after the growth of its Research segment slowed from 7% to 4%. Gartner cited weaker demand for IT advisory subscriptions and tighter tech budgets amid macro / tariff uncertainty, which hurt RELX's shares. We do not believe there is read across, and we view RELX as a demonstrative beneficiary to AI - it is seeing more efficient and faster product development, and the organic growth of Legal & STM is already accelerating. This was highlighted in the most recent interim results in July which saw faster growth in both divisions.
Great Portland Estates,
a property company, has underperformed in recent months as concerns over the fiscal deficit in the
Admiral Group
was the top contributor following strong H1'25 results with both
The shape of market returns this month has meant that performance has been driven more by what we do not own than what we do. Companies such as
National Grid
,
Barclays
and
SSE
underperformed during the period given a more risk-on environment in markets, and hawkish BoE messaging saw Experian fall over concerns for ongoing mortgage affordability. Coke bottler
Changes
We have sold Derwent as we have continued to focus our positioning in Great Portland where we added further to the position. We believe Derwent to be inexpensive but without the required change in strategy, the current market conditions will continue to overwhelm the shares. We also sold WH Smith given the disappointing update from the company during the month, which came as a surprise and fundamentally breeches the investment case in our view.
We have added to Unilever given our underweight to the staples sector more broadly and as the company is starting to execute well. We also added to RELX on recent weakness, where we believe fears have been overblown.
Outlook
The outlook for investment markets continues to be driven by a complex interplay of elevated geopolitical uncertainty, easing monetary policy and resilient demand. 1H25 saw global markets fall sharply as tariffs were threatened only to be followed by an impressive recovery as proposed tariff levels were lowered and their implementation delayed. However, tariffs remain a key source of market volatility with the potential for outsized impacts on specific industries and companies. Expectations of Fed rate cuts have consistently been pushed out this year with two cuts now expected in 2H25. US
The outlook for
In the
The
We continue to focus the portfolio on cash generative businesses that we believe offer durable, competitive advantages as we believe these companies are best placed to drive returns over the long term. Whilst we anticipate economic and market volatility will persist throughout the year, we are excited by the opportunities this will likely create; by seeking to identify the companies that strengthen their long-term prospects as well as attractive turnaround situations.